Skip to content

Ultrasound guided Transversus Abdominis Plane block: An evaluation of its efficacy in reducing post-op opioid requirements in Caesarean section

Parturients undergoing elective Caesarean section, Transversus Abdominis Plane block compared to intravenous Morphine via Patient Controlled Analgesia PCA to achieve better Postoperative pain control.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000262606
Enrollment
60
Registered
2014-03-11
Start date
2013-06-22
Completion date
2014-06-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The transversus abdominis plane (TAP) block is a new regional anaesthesia technique that provides analgesia to the peritoneum, skin as well as the muscles of the anterior abdominal wall. It is easy to perform with a high margin of safety, especially under ultrasound guidance. TAP blocks have been described as an effective component of multimodal postoperative analgesia for a wide variety of abdominal procedures including caesarean section. Current reports demonstrated its safety and efficacy in reducing opioids consumption. Post-op analgesia in patient undergoing emergency caesarean section has conventionally been a multi-modal analgesia comprising of morphine PCA, regular paracetamol and NSAIDs. These have resulted in large consumption of morphine which is excreted via breast milk. These also result in higher sedation score and higher incidence of post operative nausea and vomiting

Interventions

Arm 1 patients will receive TAP block, 0.25% Bupivacaine 20 ml bilaterally along with PCA Morphine Arm 2 patients will receive TAP block, 0.166% bupivacaine 30 ml bilaterally along with PCA Morphine TAP block is administered immediatly post caesarean section after skin suturing. PCA Morphine is made available in immediate post operative period in recovery room. PCA 1mg morphine per dose. lockout interval of 5 minutes. no background infusion and Maximum of 30 mg morphine per 4 hours.

Sponsors

Shahid Adeel
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Elective caesarean section. ASA 1 and ASA 2 patients. Patients receiving Spinal anaesthesia for surgery.

Exclusion criteria

Emergency caesarean sections. ASA 3 and ASA 4 patients. Morbidly Obese patients. Patients with local anaesthesia allergy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026